Results 91 to 100 of about 1,896 (179)
BackgroundSeasonal Malaria Chemoprevention (SMC) is currently recommended for children under five in areas where malaria transmission is highly seasonal.
Gifty D Antwi+6 more
doaj +1 more source
Background In 2014, the Burkina Faso government launched the Seasonal Malaria Chemoprevention (SMC) programme. Expected benefit was a 75% reduction of all malaria episodes and a 75% drop of severe malaria episodes.
Fati Kirakoya-Samadoulougou+4 more
doaj +1 more source
Abstract This article is based on the observation that the affected populations perceive existing community‐based adaptation strategies to the health effects of floods differently. We explore the resilience of the local health system to climate change (CC) in Keur Massar (Senegal) using a monographic approach based on a qualitative survey of flooded ...
Abdoulaye Moussa Diallo, Valery Ridde
wiley +1 more source
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial [PDF]
AbstractObjectiveTo investigate the effectiveness of seasonal malaria chemoprevention (SMC) and community case management with long‐acting artemisinin‐based combination therapies (ACTs) for the control of malaria in areas of extended seasonal malaria transmission.MethodIndividually randomised, placebo‐controlled trial in the Ashanti Region of Ghana.
Daniel Chandramohan+5 more
openaire +4 more sources
Abstract Clinical pharmacology is often the nexus in any cross‐disciplinary team that is seeking solutions for human healthcare issues. The use and application of real‐world data and artificial intelligence to better understand our ecosystem has influenced our view at the world and how we do things.
Tirhani Maluleke+13 more
wiley +1 more source
Abstract Background Severe Plasmodium falciparum malarial anemia is still the principal cause of death in children in underdeveloped countries. An imbalance between proinflammatory and anti‐inflammatory cytokines is associated with malaria progression.
Charles Nkansah+25 more
wiley +1 more source
Background Seasonal malaria chemoprevention (SMC) consists of administration of sulfadoxine-pyrimethamine (SP) + amodiaquine (AQ) at monthly intervals to children during the malaria transmission period.
Koudraogo Bienvenue Yaméogo+13 more
doaj +1 more source
Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal [PDF]
In sub-Saharan Africa, malaria is the leading cause of morbidity and mortality especially in children. In Senegal, seasonal malaria chemoprevention (SMC) previously referred to as intermittent preventive treatment in children (IPTc) is a new strategy for malaria control in areas of high seasonal transmission.
Lo, A. C.+18 more
openaire +5 more sources
Abstract Background Seasonal malaria chemoprevention using sulfadoxine‐pyrimethamine plus amodiaquine (sulfadoxine‐pyrimethamine plus amodiaquine on Day 1 and amodiaquine on both Day 2 and Day 3) is delivered to children aged 3–59 months in areas of highly season malaria transmission.
Sikai Huang+5 more
wiley +1 more source
The use of formative research to inform the design of a seasonal malaria chemoprevention intervention in northern Nigeria [PDF]
Experience of seasonal malaria chemoprevention (SMC) is growing in the Sahel sub-region of Africa, though there remains insufficient evidence to recommend a standard deployment strategy. In 2012, a project was initiated in Katsina state, northern Nigeria, to design an appropriate and effective community-based delivery approach for SMC, in consultation ...
Madeleine Marasciulo+14 more
openaire +4 more sources